Oracle Health Sciences
has strengthened its analytics offerings with the release of
Oracle® Clinical Development Analytics 2.0
and
Oracle Life Sciences Data Hub 2.1.4
.
Oracle’s life sciences analytics solutions help organizations accelerate insight and increase research and development efficiency. Oracle Clinical Development Analytics 2.0 expands beyond the product’s original focus on clinical data management to provide rich content for clinical operations.
With more than 360 pre-built and pre-sourced metrics and associated attributes, Oracle Clinical Development Analytics 2.0 enables life sciences organizations to gain insight into trial and program performance and make more informed business decisions by helping them to:
For comprehensive insight across the clinical trial environment, Oracle Clinical Development Analytics 2.0 now sources data directly from Oracle’s Siebel Clinical Trial Management System, in addition to information from Oracle Clinical and Oracle Remote Data Capture.
Oracle Life Sciences Data Hub 2.1.4 is a validated and secure data repository that integrates clinical, non-clinical and safety data from multiple sources into a unified environment. This helps enable organizations to streamline business processes around trial data acquisition, analysis and reporting. Updates to the latest version help:
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE)
February 13th 2025Peter Wahl, PhD, VP of Global Scientific Affairs at CorEvitas, discusses the critical role of protocol-driven registries in generating regulatory-grade RWE for safety, effectiveness, and regulatory decision-making. He covers key considerations for selecting the right type of registry, the advantages over EMR datasets, and how registries fulfill FDA and EMA post-marketing safety requirements.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.